A young onset Parkinson's patient: a case study.
Young onset Parkinson's disease (YOPD) is defined as idiopathic Parkinson's disease (IPPD) occurring in people between 21 and 40 years of age; it strikes approximately 5% of Parkinson's patients. YOPD has earlier onset of motor complications than later onset Parkinson's disease. Motor complications and disease progression are responsible for devastating morbidity. Current medical and surgical treatments can dramatically ameliorate motor complications and help maintain function and employment. Patient education, support, and advocacy provided by nursing staff can influence the treatment options for these patients, having a significant effect on the future course of the disease. This case history documents the course of a YOPD patient with unusually severe motor complications. He is the only patient at Puget Sound Neurology ever to develop rhabdomyolysis due to dyskinesias. Following bilateral subthalamic nucleus deep brain stimulation, his Parkinson's symptoms have improved dramatically, and his motor complications are significantly improved.
Jung
Sharon K
SK
Puget Sound Neurology, Tacoma, WA, USA. sjung@harbornet.com
D000203:Activities of Daily Living; D000328:Adult; D017668:Age of Onset; D000547:Amantadine / Q000627:therapeutic use; D000978:Antiparkinson Agents / Q000627:therapeutic use; D002230:Carbidopa / Q000627:therapeutic use; D003131:Combined Modality Therapy; D046690:Deep Brain Stimulation; D003987:Dibenzothiazepines / Q000627:therapeutic use; D018450:Disease Progression; D020820:Dyskinesias / Q000209:etiology; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D008297:Male; D009048:Motor Skills; D024802:Nurse's Role; D010300:Parkinson Disease / Q000150:complications / Q000523:psychology / Q000628:therapy*; D010344:Patient Advocacy; D010353:Patient Education as Topic; D011788:Quality of Life; D000069348:Quetiapine Fumarate; D012206:Rhabdomyolysis / Q000209:etiology; D012720:Severity of Illness Index; D012944:Social Support; D016896:Treatment Outcome
D000978:Antiparkinson Agents; D003987:Dibenzothiazepines; D000069348:Quetiapine Fumarate; D007980:Levodopa; D000547:Amantadine; D002230:Carbidopa